348 related articles for article (PubMed ID: 28986052)
1. An effective algorithm for the serological diagnosis of idiopathic inflammatory myopathies: The key role of anti-Ro52 antibodies.
Infantino M; Manfredi M; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Bizzaro N
Clin Chim Acta; 2017 Dec; 475():15-19. PubMed ID: 28986052
[TBL] [Abstract][Full Text] [Related]
2. A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.
Tampoia M; Notarnicola A; Abbracciavento L; Fontana A; Giannini M; Louis Humbel R; Iannone F
J Clin Lab Anal; 2016 Nov; 30(6):859-866. PubMed ID: 27074881
[TBL] [Abstract][Full Text] [Related]
3. Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis.
Infantino M; Tampoia M; Fabris M; Alessio MG; Previtali G; Pesce G; Deleonardi G; Porcelli B; Musso M; Grossi V; Benucci M; Manfredi M; Bizzaro N
Rheumatology (Oxford); 2019 Jul; 58(7):1239-1244. PubMed ID: 30726990
[TBL] [Abstract][Full Text] [Related]
4. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.
Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF; Levesque H; Jouen F
Semin Arthritis Rheum; 2012 Jun; 41(6):890-9. PubMed ID: 22078416
[TBL] [Abstract][Full Text] [Related]
5. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
[TBL] [Abstract][Full Text] [Related]
6. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy.
Huang HL; Lin WC; Yeh CC; Sun YT
J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271
[TBL] [Abstract][Full Text] [Related]
7. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy.
Rutjes SA; Vree Egberts WT; Jongen P; Van Den Hoogen F; Pruijn GJ; Van Venrooij WJ
Clin Exp Immunol; 1997 Jul; 109(1):32-40. PubMed ID: 9218821
[TBL] [Abstract][Full Text] [Related]
8. Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.
Piette Y; De Sloovere M; Vandendriessche S; Dehoorne J; De Bleecker JL; Van Praet L; Vander Mijnsbrugge AS; De Schepper S; Jacques P; De Keyser F; Smith V; Bonroy C
Clin Exp Rheumatol; 2020; 38(2):212-219. PubMed ID: 31287411
[TBL] [Abstract][Full Text] [Related]
9. A Negative Antinuclear Antibody Does Not Indicate Autoantibody Negativity in Myositis: Role of Anticytoplasmic Antibody as a Screening Test for Antisynthetase Syndrome.
Aggarwal R; Dhillon N; Fertig N; Koontz D; Qi Z; Oddis CV
J Rheumatol; 2017 Feb; 44(2):223-229. PubMed ID: 27909085
[TBL] [Abstract][Full Text] [Related]
10. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
[TBL] [Abstract][Full Text] [Related]
11. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
[TBL] [Abstract][Full Text] [Related]
12. Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study.
Infantino M; Palterer B; Biagiotti R; Almerigogna F; Benucci M; Damiani A; Grossi V; Azzurri A; Casprini P; Bacci G; Giudizi MG; Manfredi M
Immunol Res; 2018 Feb; 66(1):74-78. PubMed ID: 29159696
[TBL] [Abstract][Full Text] [Related]
13. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies.
Frank MB; McCubbin V; Trieu E; Wu Y; Isenberg DA; Targoff IN
J Autoimmun; 1999 Mar; 12(2):137-42. PubMed ID: 10047434
[TBL] [Abstract][Full Text] [Related]
14. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
[TBL] [Abstract][Full Text] [Related]
15. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
[TBL] [Abstract][Full Text] [Related]
16. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
17. Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease.
Gui X; Shenyun S; Ding H; Wang R; Tong J; Yu M; Zhao T; Ma M; Ding J; Xin X; Qiu Y; Qiu X; Zhang Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y
Rheumatology (Oxford); 2022 Nov; 61(11):4570-4578. PubMed ID: 35148366
[TBL] [Abstract][Full Text] [Related]
18. Concordance between myositis autoantibodies and anti-nuclear antibody patterns in a real-world, Australian cohort.
He J; Wei X; Sturgess A
Rheumatology (Oxford); 2022 Aug; 61(9):3792-3798. PubMed ID: 35048956
[TBL] [Abstract][Full Text] [Related]
19. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
20. Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.
Amlani A; Choi MY; Tarnopolsky M; Brady L; Clarke AE; Garcia-De La Torre I; Mahler M; Schmeling H; Barber CE; Jung M; Fritzler MJ
Front Immunol; 2019; 10():745. PubMed ID: 31024569
[No Abstract] [Full Text] [Related]
[Next] [New Search]
